Brittany Matheson

Stanford University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background Anorexia nervosa is a severe psychiatric disorder with high morbidity and mortality, particularly among adolescents. Family-based treatment (FBT) is the leading evidence-based intervention for adolescent anorexia nervosa, involving parents in renourishment and behavior interruption. Despite its effectiveness, challenges in distress tolerance and emotion regulation during high-stress situations, such as mealtimes, contribute to suboptimal treatment outcomes, with only 35% to 50% of adolescents achieving full recovery. Enhancing distress tolerance skills during FBT may improve treatment responses and recovery rates. The BALANCE mobile app was developed to address this need, offering real-time, dialectical behavior therapy (DBT)–based distress tolerance skills to support adolescents and families during mealtimes. Objective Our aim was to explore the feasibility and acceptability of a mobile app designed to deliver distress tolerance skills to adolescents with and adolescents without anorexia nervosa. When fully programmed and optimized, we plan to use the mobile app to improve distress tolerance during mealtimes for adolescents with anorexia nervosa undergoing FBT. Methods BALANCE was developed collaboratively with Stanford University’s Center for Biodesign, leveraging the expertise of clinical psychologists and using biodesign student input and the Stanford Spezi ecosystem. The app underwent an iterative development process, with feedback from adolescent users. The initial feasibility and acceptability of the app were assessed through self-reported questionnaires and structured interviews with 24 adolescents aged 12 to 18 years, including 4 diagnosed with anorexia nervosa and 20 healthy controls. Adolescents with anorexia nervosa specifically used the app during mealtimes, and healthy controls used it as needed. Participants assessed the app’s usability, perceived effectiveness, and its impact on their distress tolerance. Results The app demonstrated high usability and acceptability. Of 24 participants, 83% (n=20) reported enjoying the app, 88% (n=21) would recommend it to peers, and 100% (n=24) found it user-friendly. Adolescents with anorexia nervosa reported that BALANCE helped them manage stressful mealtimes more effectively, highlighting features such as guided meditation, breathing exercises, and gamification elements as particularly effective. Healthy controls provided additional feedback, confirming the app’s broad appeal to the target audience and potential scalability. Preliminary findings suggest that BALANCE may enhance distress tolerance in adolescents with and adolescents without anorexia nervosa. Conclusions BALANCE shows promise as an innovative mobile health intervention for enhancing distress tolerance in adolescents with anorexia nervosa. Its user-friendly design and tailored DBT-based skills make it a feasible tool for integration into FBT. Future research should explore its integration into clinical practice and its impact on treatment outcomes. As distress tolerance skills are relevant to a range of mental health conditions, future research may also expand BALANCE’s application to broader adolescent populations.

Year:

2025

Background Online training programs offer accessible, cost-effective solutions to disseminate evidence-based interventions. Yet, online training is typically insufficient without additional clinical case consultation (CCC). This is particularly salient in adolescent eating disorders treatment, where clinical demand far outstrips capacities of providers trained in evidence-based treatment approaches. This study seeks to better understand attitudes and barriers to receiving CCC among private practice clinicians treating adolescent eating disorders. Methods Licensed private practice clinicians ( n = 47; 100% female, average age 36 y old; 75% master’s degree; average of 4y experience) across the United States enrolled in a randomized trial offering online training (webinar or e-learning) in family-based treatment (FBT) for anorexia nervosa. Post online training, participants were asked before and after 12 sessions of expert CCC to self-report attitudes and barriers to obtaining CCC. Results Prior to CCC, participants rated expert CCC in learning FBT as important/very important (100%). The majority participated in CCC since licensure (82%) and in the last year (68%), rating it valuable or very valuable (77%). Participants predicted that CCC would be valuable (96%) and an important motivation in completing the training study (96%). After CCC, participants viewed CCC as important/very important in learning FBT (94%). Common obstacles included finding a study-eligible patient (44%), scheduling constraints (19%), lost wages (16%), mismatch with consultant (3%), and hesitation to discuss cases (3%). Conclusions Clinicians reported favorable perspectives on CCC in complimenting learning FBT via online training. Future studies are needed to determine methods to deliver, assess, and scale CCC to enhance treatment fidelity.

Year:

2025

Objective Describe the feasibility, acceptability and preliminary efficacy of family‐based treatment for adolescents with avoidant/restrictive food intake disorders (FBT‐ARFID) in a real‐world clinical cohort. Explore differences between adolescents and younger children with ARFID using FBT‐ARFID. Method A retrospective chart review from 2017 to 2023 identified 39 children (< age 13) and 40 adolescents (age 13–18) who were assessed and then treated with FBT‐ARFID in an outpatient clinic at a large academic medical hospital. We pulled data from patient charts on demographics and clinical characteristics and completed chart reviews for clinical outcome data (acceptability, feasibility, hospitalization rates, concurrent treatments, and parental learning). We used independent sample t tests and χ 2 testing, and reported effect size differences on comparisons. Results A total of 46/55 (84%) children began FBT‐ARFID after an initial evaluation (feasibility), and of those, 39 (85%) received more than four sessions (acceptability). A total of 42/66 (64%) adolescents started FBT‐ARFID; of those, 40 (95%) received more than four sessions of FBT‐ARFID. Children and adolescents presented similarly prior to treatment and achieved comparable practical clinical outcomes when treated with FBT‐ARFID. There were more neurodivergent adolescents receiving FBT‐ARFID than children, defined as diagnoses of comorbid ASD, ADHD, or both (37% vs. 15%). Adolescents used a greater number of sessions ( M = 21, SD = 11.9) compared to children receiving FBT‐ARFID ( M = 15.2, SD = 7.4). Conclusions Findings from this retrospective outpatient clinic chart review indicate that FBT‐ARFID is feasible for treating, retaining, and obtaining clinical outcomes in adolescents.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (8)

Hyun-Joon Yang

Stanford University School of Medicine

UNITED STATES
View details

Bohye Kim

-

SOUTH KOREA
View details

James Lock

-

UNITED STATES
View details

Vishnu Ravi

Clinical Assistant Professor of Medicine

Stanford University

UNITED STATES
View details

Cara Bohon

Assistant Professor

Stanford University

UNITED STATES
View details

Franziska Plessow

Assistant Professor of Medicine

Massachusetts General Hospital and Harvard Medical School

UNITED STATES
View details

Booil Jo

Associate Professor

Stanford University

UNITED STATES
View details

Erin E. Reilly

-

UNITED STATES
View details